Table of contents

ORIGINAL ARTICLE

• Preliminary toxicity analysis of intraperitoneal carboplatin in combination with intravenous paclitaxel chemotherapy for patients with carcinoma of the ovary, peritoneum, or fallopian tube (1 April, 2005)

  K. Fujiwara, S. Suzuki, H. Ishikawa, T. Oda, E. Aotani, I. Kohno
• Clear-cell cancer of the ovary—is it chemosensitive? (1 April, 2005)

  S. Pather, M. A. Quinn
• Quantitative biochemical analysis of lactate dehydrogenase in human ovarian tissues: correlation with tumor grade (1 April, 2005)

  Š. ŠIMAGA, M. Osmak, D. Babič, M. ŠPREM, B. Vukelič, M. Abramič
• Chemosensitivity testing of ovarian cancer using the histoculture drug response assay: sensitivity to cisplatin and clinical response (1 April, 2005)

  S. Nakada, D. Aoki, S. Ohie, M. Horiuchi, N. Suzuki, M. Kanasugi, N. Susumu, Y. Udagawa, S. Nozawa
• Diagnostic approach using the expression profiling of the P53 tumor suppressor gene and its related proteins in ovarian epithelial tumors (1 April, 2005)

  H. Lee, G. Park, J. H. Jung, W. S. Ahn, J. M. Lee, B. K. Kim, C. S. Kang
• Ultrastructure alterations in adriamycin-resistant and cisplatin-resistant human ovarian cancer cell lines exposed to nonlethal ultrasound (1 April, 2005)

  T. Yu, X. Huang, S. Jiang, K. Hu, B. Kong, Z. Wang
• Effect of radiotherapy on pelvic lymph node metastasis in cervical cancer stages IB2–IVA: a retrospective analysis of two comparative series (1 April, 2005)

  D. Dargent, G. Lamblin, P. Romestaing, X. Montbarbon, P. Mathevet, M. Benchaib
• Pelvic exenterations for gynecological malignancies: twenty-year experience at Roswell Park Cancer Institute (1 April, 2005)

  S. Sharma, K. Odunsi, D. Driscoll, S. Lele
• Comparative study of chemoradiation and neoadjuvant chemotherapy effects before radical hysterectomy in stage IB–IIB bulky cervical cancer and with tumor diameter greater than 4 cm (1 April, 2005)

  M. Modarress, F. Q. Maghami, M. Golnavaz, N. Behtash, A. Mousavi, G. R. Khalili
• Can we substitute brush cytology for biopsy in the evaluation of cervical lesions under the guidance of colposcopy? (1 April, 2005)

  Z. Eftekhar, N. Izadi-Mood, F. Yarandi, M. Khodamoradi, P. Rahimi-Moghaddam
• Radioguided sentinel lymph node detection in vulvar cancer (1 April, 2005)

  C. Merisio, R. Berretta, M. Gualdi, D. C. Pultrone, S. Anfuso, G. Agnese, C. Aprile, L. Mereu, S. Salamano, S. Tateo, M. Melpignano
• Outcomes of abandoned radical hysterectomy in patients with stages IB–IIA cervical cancer found to have positive nodes during the operation (1 April, 2005)

  P. Suprasert, J. Srisomboon, K. Charoenkwan, S. Siriaungul, S. Khunamornpong, S. Siriaree, C. Phongnarisorn, V. Lorvidhaya
• Upregulation of heat shock protein 27 in metaplastic and neoplastic lesions of the endocervix (1 April, 2005)

  A. A. El-Ghobashy, A. M. Shaaban, J. Innes, W. Prime, C. S. Herrington
• Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy (1 April, 2005)

  B. M. Slomovitz, L. M. Ramondetta, C. M. Lee, J. C. Oh, P. J. Eifel, A. Jhingran, T. W. Burke, D. M. Gershenson, K. H. Lu
• Abnormal cervical cytology: a risk factor for endometrial cancer recurrence (1 April, 2005)

  A. K. Brown, S. Gillis, C. Deuel, C. Angel, C. Glantz, B. Dubeshter
• Receptorial and mitochondrial apoptotic pathways in normal and neoplastic human endometrium (1 April, 2005)

  M. Di Paola, G. Loverro, A. M. Caringella, G. Cormio, L. Selvaggi
• Is aromatase cytochrome P450 involved in the pathogenesis of endometrioid endometrial cancer? (1 April, 2005)

  V. H. W. M. Jongen, J. H. H. Thijssen, H. Hollema, G. H. Donker, J. G. Santema, A. G. J. Van Der Zee, M. J. Heineman
• Expression of estrogen receptors ERα and ERβ in endometrial hyperplasia and adenocarcinoma (1 April, 2005)

  K. Hu, G. Zhong, F. He